Literature DB >> 8787457

Influence of ejection fraction on hospital mortality, morbidity, and costs for CABG patients.

G L Kay1, G W Sun, A Aoki, C A Prejean.   

Abstract

BACKGROUND: Preoperative ejection fraction (EF) has been shown to adversely affect postoperative hospital mortality and morbidity for patients undergoing isolated coronary artery bypass grafting.
METHODS: To investigate influence of EF on isolated coronary artery bypass grafting outcomes (overall hospital mortality, hospital cardiac mortality, hospital morbidity, and hospital costs), data were reviewed from 1,354 consecutive patients who underwent isolated coronary artery bypass grafting between January 1, 1990, and April 30, 1992, at a single nonprofit hospital. Overall hospital mortality was 4.06% (cardiac, 2.36%). Hospital morbidity was 14.25% (including mortality). Hospital costs (not charges) averaged $16,673 per patient. To explore the impact of preoperative EF, EF was stratified into regular intervals. Each interval was then compared with regard to hospital mortality, morbidity, and average costs. A new statistical tool, discharge analysis, was developed to analyze the cost data. This was necessary because previous efforts at cost analysis have used tools inappropriate for real world cost data.
RESULTS: The statistical analysis showed that patients with EF of 0.40 or greater had the best outcomes (lowest mortality, morbidity, and cost). Once the EF is 0.40 or greater the EF does not carry further predictive value. At EF less than 0.40, patients with EF less than 0.30 have a poorer outcome than patients with EF of 0.30 to 0.39.
CONCLUSIONS: (1) Ejection fraction is a valid predictor of mortality, morbidity and resource utilization based on statistical analysis. (2) Patients can be broadly grouped as having EF greater than 0.40, less than 0.30, or from 0.30 to 0.39 with regard to clinical and cost outcomes. (3) Postoperative length of stay is not predicted by risk-adjusted EF. (4) A new tool, discharge analysis, is presented to facilitate cost analysis.

Entities:  

Mesh:

Year:  1995        PMID: 8787457     DOI: 10.1016/0003-4975(95)00894-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Surgeons' economic profiles: can we get the "right" answers?

Authors:  Eric L Eisenstein; Charles F Bethea; Lawrence H Muhlbaier; Marie Davidian; Eric D Peterson; Judith A Stafford; Daniel B Mark
Journal:  J Med Syst       Date:  2005-04       Impact factor: 4.460

2.  Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction.

Authors:  André L Hovnanian; Alexandre de Matos Soeiro; Carlos Vicente Serrano; Sérgio Almeida de Oliveira; Fábio B Jatene; Noedir A G Stolf; José A F Ramires
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

3.  An Optimized Machine Learning Model Accurately Predicts In-Hospital Outcomes at Admission to a Cardiac Unit.

Authors:  Sandeep Chandra Bollepalli; Ashish Kumar Sahani; Naved Aslam; Bishav Mohan; Kanchan Kulkarni; Abhishek Goyal; Bhupinder Singh; Gurbhej Singh; Ankit Mittal; Rohit Tandon; Shibba Takkar Chhabra; Gurpreet S Wander; Antonis A Armoundas
Journal:  Diagnostics (Basel)       Date:  2022-01-19

4.  Can Pre-Operative HbA1c Values in Coronary Surgery be a Predictor of Mortality?

Authors:  Bahar Aydınlı; Aslı Demir; Harun Özmen; Özden Vezir; Utku Ünal; Mustafa Özdemir
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.